Drug Shortage Report for TEVA-RISPERIDONE

Last updated on 2023-10-03 History
Report ID 1566
Drug Identification Number 02264188
Brand name TEVA-RISPERIDONE
Common or Proper name RISPERIDONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RISPERIDONE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-01
Estimated end date 2018-11-01
Actual end date 2018-11-01
Shortage status Resolved
Updated date 2023-10-03
Company comments Item is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2023-10-03 English Compare
v4 2023-10-03 French Compare
v5 2023-10-03 English Compare
v6 2023-10-03 French Compare
v7 2023-10-03 English Compare
v8 2023-10-03 French Compare

Showing 1 to 8 of 8